GBA1 and Parkinson disease: We detected approximately a 50% increase in TFEB activity in PD cells corrected for the GBA1-N370S mutation compared to the parent mutant cells (Figures 2B,C) and treatment with Torin1 increased the activity in both the mutant and the gene-edited iPSCs (Figure 2B).